Updated Jul 16, 2026
Lynch Ryan has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $8K.

Lynch Ryan appears in SEC filings as an individual associated with Crescent Biopharma, Inc. as of June 23, 2026. The provided excerpt does not include a specific title or role, and there are no additional public biographical details available from the given context. Based on the SEC filing context, this appears to be an insider/official association with the company rather than a widely public figure.
| Role | See Remarks |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | CBIO | CRESCENT BIOPHARMA, INC. | S — Open-market sale | 465 | $17.99 | $8K |
Lynch Ryan appears in SEC filings as an individual associated with Crescent Biopharma, Inc. as of June 23, 2026. The provided excerpt does not include a specific title or role, and there are no additional public biographical details available from the given context. Based on the SEC filing context, this appears to be an insider/official association with the company rather than …
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($8K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lynch Ryan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.